HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo F Caimi Selected Research

Lenalidomide (CC 5013)

9/2023Tafasitamab and lenalidomide in large B cell lymphoma: real-world outcomes in a multicenter retrospective study.
1/2023Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo F Caimi Research Topics

Disease

16Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2024 - 11/2015
15Lymphoma (Lymphomas)
05/2024 - 03/2010
13Neoplasms (Cancer)
05/2024 - 07/2015
11Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2023 - 01/2019
9B-Cell Lymphoma (Lymphoma, B Cell)
05/2024 - 01/2019
7Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 09/2015
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2023 - 08/2016
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2023 - 01/2021
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2021 - 01/2016
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2019
2Neutropenia
12/2021 - 01/2021
2Hodgkin Disease (Hodgkin's Disease)
06/2021 - 07/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2024
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024
1Inflammation (Inflammations)
01/2023
1Central Nervous System Diseases (CNS Diseases)
11/2022
1Heart Failure
10/2022
1Frailty
01/2022
1Diarrhea
12/2021
1cell-associated neurotoxicity
12/2021
1Cytokine Release Syndrome
12/2021
1Disease Progression
01/2021
1Nausea
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Fatigue
01/2021
1Carcinogenesis
01/2021
1Edema (Dropsy)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Leukemia
01/2020
1AIDS-Related Complex (ARC)
11/2019
1Multiple Myeloma
08/2016
1Cardiotoxicity
01/2016

Drug/Important Bio-Agent (IBA)

8Immunoconjugates (Immunoconjugate)IBA
05/2024 - 03/2010
8loncastuximab tesirineIBA
05/2024 - 01/2021
6Chimeric Antigen ReceptorsIBA
05/2023 - 01/2020
5Rituximab (Mabthera)FDA Link
10/2023 - 11/2015
5Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2019
4AnthracyclinesIBA
10/2022 - 01/2016
3Monoclonal AntibodiesIBA
05/2023 - 03/2010
2Lenalidomide (CC 5013)FDA Link
09/2023 - 01/2023
2AntigensIBA
05/2023 - 01/2022
2Cytarabine (Cytosar-U)FDA LinkGeneric
11/2022 - 01/2019
2umbralisibIBA
12/2021 - 01/2021
1Inotuzumab OzogamicinIBA
01/2024
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2023
1Biomarkers (Surrogate Marker)IBA
10/2023
1tafasitamabIBA
09/2023
1AntibodiesIBA
05/2023
1EpitopesIBA
05/2023
1blinatumomabIBA
05/2023
1axicabtagene ciloleucelIBA
01/2023
1tisagenlecleucelIBA
01/2023
1Chlorambucil (Leukeran)FDA Link
01/2023
1CytokinesIBA
01/2023
1Methotrexate (Mexate)FDA LinkGeneric
11/2022
1Vincristine (Oncovin)FDA LinkGeneric
11/2022
1selinexorIBA
01/2022
1serum P-component (CIt)IBA
01/2022
1ibrutinibIBA
01/2022
1Azacitidine (5 Azacytidine)FDA Link
01/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2021
1Transaminases (Aminotransferases)IBA
12/2021
1CD19 AntigensIBA
12/2021
1Phosphotransferases (Kinase)IBA
11/2021
1Filgrastim (Neupogen)FDA Link
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Nuclear Proteins (Protein, Nuclear)IBA
01/2021
1EnzymesIBA
01/2021
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2021
1RO6870810IBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1Immune Checkpoint InhibitorsIBA
07/2020
1LithiumIBA
01/2020
1CalciumIBA
01/2020
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020
1AlbuminsIBA
01/2020
1Glycogen Synthase (Synthase I)IBA
01/2020
1pyrrolo(2,1-c)(1,4)benzodiazepineIBA
01/2019
1Cell Surface ReceptorsIBA
01/2019
1Cyclin D1IBA
01/2019
1fludarabineIBA
10/2017
1methoxyamineIBA
10/2017
1Bortezomib (Velcade)FDA Link
08/2016
1Proteasome InhibitorsIBA
08/2016
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2016

Therapy/Procedure

25Therapeutics
05/2024 - 11/2015
4Cell Transplantation
03/2024 - 07/2015
4Drug Therapy (Chemotherapy)
01/2023 - 08/2015
3Transplantation
03/2024 - 01/2022
2Induction Chemotherapy
10/2023 - 01/2019
2Radiotherapy
10/2023 - 11/2022
2Aftercare (After-Treatment)
11/2021 - 08/2015
2Salvage Therapy
01/2021 - 01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
05/2023
1Injections
01/2023
1Stem Cell Transplantation
01/2023
1Hematopoietic Stem Cell Transplantation
01/2022
1Immunotherapy
12/2021
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2019
1Drug Tapering
01/2016